Results 71 to 80 of about 20,658 (229)

Comparison of three radiodiagnostic techniques for pyrophosphate arthropathy

open access: yesНаучно-практическая ревматология, 2012
Pyrophosphate arthropathy (PPA) is a disease that arises due to the formation and deposition of calcium pyrophosphate crystals within the articular cartilage and thereby develops into immune inflammation.
Fatima Magomedovna Kudayeva   +4 more
doaj   +1 more source

CALCIUM PYROPHOSPHATE DIHYDRATE DEPOSITION DISEASE OF ELBOW WITH ULNAR NERVE NEUROPATHY: A CASE REPORT

open access: yesJournal of Chitwan Medical College, 2023
Crystal deposition disorders are one of the causes of inflammatory arthropathy. A rare variety of this disorder is Calcium Pyrophosphate Dihydrate deposition disease.
Sunil Panta   +4 more
semanticscholar   +1 more source

Articular cartilage mineralization in osteoarthritis of the hip [PDF]

open access: yes, 2009
Background The aim of this study was to examine the frequency of articular cartilage calcification in patients with end-stage hip OA. Further, its impact on the clinical situation and the OA severity are analyzed.
Martin Fuerst   +28 more
core   +1 more source

Diagnosis of calcium pyrophosphate crystal deposition disease by ultrasonography: how many and which sites should be scanned?

open access: yesRheumatology, 2023
Objective To develop the optimal US scanning protocol for the diagnosis of calcium pyrophosphate crystal deposition (CPPD) disease. Methods In this cross-sectional study, consecutive patients with a crystal-proven diagnosis of CPPD disease, and age-, sex-
E. Cipolletta   +11 more
semanticscholar   +1 more source

New insights into NPP1 function:Lessons from clinical and animal studies [PDF]

open access: yes, 2012
The recent elucidation of rare human genetic disorders resulting from mutations in ectonucleotide pyrophosphotase/phosphodiesterase (ENPP1), also known as plasma cell membrane glycoprotein 1 (PC-1), has highlighted the vital importance of this molecule ...
Huesa, C   +3 more
core   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun   +4 more
wiley   +1 more source

Phospho1 deficiency transiently modifies bone architecture yet produces consistent modification in osteocyte differentiation and vascular porosity with ageing [PDF]

open access: yes, 2015
PHOSPHO1 is one of principal proteins involved in initiating bone matrix mineralisation. Recent studies have found that Phospho1 KO mice (Phospho1-R74X) display multiple skeletal abnormalities with spontaneous fractures, bowed long bones, osteomalacia ...
Carriero, A   +11 more
core   +4 more sources

Imaging of Crystal Disorders:: Calcium Pyrophosphate Dihydrate Crystal Deposition Disease, Calcium Hydroxyapatite Crystal Deposition Disease and Gout Pathophysiology, Imaging, and Diagnosis.

open access: yesThe Radiologic clinics of North America, 2022
Crystal arthropathies are a group of joint disorders due to deposition of crystals in and around joints that lead to joint destruction and soft tissue masses. Clinical presentation is variable and diagnosis might be challenging.
M. Reijnierse, C. Schwabl, A. Klauser
semanticscholar   +1 more source

A phenomap of TTR amyloidosis to aid diagnostic screening

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1113-1118, April 2025.
Abstract Cardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical practice.
Alexios S. Antonopoulos   +4 more
wiley   +1 more source

THE CLINICAL MANIFESTATIONS OF CALCIUM PYROPHOSPHATE CRYSTAL DEPOSITION DISEASE

open access: yesНаучно-практическая ревматология, 2014
Objective: to provide the clinical characteristics of joint injury in patients with calcium pyrophosphate crystal (CPC) deposition disease.Subjects and methods. The trial enrolled 68 patients (43 women, 25 men) with a verified diagnosis of CPC deposition 
F. M. Kudaeva   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy